# Relmada Therapeutics, Inc.: filings

RLMD · Nasdaq · CIK 1553643 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rlmd.md) · [Financials](/companies/rlmd/financials.md) · [Filings](/companies/rlmd/filings.md) · [Insiders](/companies/rlmd/insiders.md)

## Reports and events: 237 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 175, 8-K 148, 10-Q 40, SC 13G/A 23, SC 13G 21, 3 17, DEFA14A 17, CORRESP 15, UPLOAD 14, 10-K 12, DEF 14A 12, S-1/A 11, EFFECT 9, 424B5 8, SCHEDULE 13G 8, D 7, S-8 7, SC 13D/A 7, 424B3 6, S-3 5, PRE 14A 4, S-1 4, SCHEDULE 13G/A 4, 4/A 3, 5 3, D/A 3, 10-KT 2, 8-K/A 2, DFAN14A 2, S-3/A 2, S-3ASR 2, 144 1, 3/A 1, 5/A 1, 8-A12B 1, 8-A12G 1, CERT 1, FWP 1, NT 10-K 1, NT 10-Q 1, POS AM 1, SC 13D 1, SEC STAFF ACTION 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-08 | 08:00 ET | [8-K](/filings/0001213900-26-097851.md) | 8.01 Other events | 0001213900-26-097851 |
| 2026-08-06 | 16:40 ET | [8-K](/filings/0001213900-26-086190.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-086190 |
| 2026-08-06 | 16:14 ET | [10-Q](/filings/0001213900-26-086151.md) | Quarterly report, period 2026-06-30 | 0001213900-26-086151 |
| 2026-07-28 | 08:35 ET | [8-K](/filings/0001213900-26-082007.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-082007 |
| 2026-05-28 | 16:59 ET | [8-K](/filings/0001213900-26-062184.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-062184 |
| 2026-05-12 | 17:00 ET | [8-K](/filings/0001213900-26-055164.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-055164 |
| 2026-05-12 | 16:05 ET | [10-Q](/filings/0001213900-26-055059.md) | Quarterly report, period 2026-03-31 | 0001213900-26-055059 |
| 2026-04-17 | 16:30 ET | [DEF 14A](/filings/0001213900-26-045192.md) | Proxy statement, period 2026-05-27 | 0001213900-26-045192 |
| 2026-03-20 | 16:52 ET | [8-K](/filings/0001213900-26-032403.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-032403 |
| 2026-03-19 | 16:25 ET | [10-K](/filings/0001213900-26-031862.md) | Annual report, period 2025-12-31 | 0001213900-26-031862 |
| 2026-03-09 | 07:11 ET | [8-K](/filings/0001213900-26-024918.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-024918 |
| 2025-12-15 | 07:50 ET | [8-K](/filings/0001213900-25-121461.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-121461 |
| 2025-11-13 | 16:58 ET | [8-K](/filings/0001213900-25-110088.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-110088 |
| 2025-11-13 | 16:07 ET | [10-Q](/filings/0001213900-25-109983.md) | Quarterly report, period 2025-09-30 | 0001213900-25-109983 |
| 2025-11-05 | 21:25 ET | [8-K](/filings/0001213900-25-106398.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-106398 |
| 2025-11-04 | 07:00 ET | [8-K](/filings/0001213900-25-105593.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-105593 |
| 2025-09-17 | 07:30 ET | [8-K](/filings/0001213900-25-088360.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-088360 |
| 2025-09-16 | 08:06 ET | [8-K](/filings/0001213900-25-087926.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-087926 |
| 2025-09-10 | 08:46 ET | [8-K](/filings/0001213900-25-086389.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-086389 |
| 2025-09-02 | 07:30 ET | [8-K](/filings/0001213900-25-082910.md) | 7.01 Regulation FD disclosure | 0001213900-25-082910 |
| 2025-08-07 | 17:01 ET | [8-K](/filings/0001213900-25-073130.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-073130 |
| 2025-08-07 | 16:06 ET | [10-Q](/filings/0001213900-25-073073.md) | Quarterly report, period 2025-06-30 | 0001213900-25-073073 |
| 2025-07-23 | 16:30 ET | [8-K](/filings/0001213900-25-066995.md) | 3.01 Delisting notice | 0001213900-25-066995 |
| 2025-07-10 | 16:30 ET | [8-K](/filings/0001213900-25-062803.md) | 1.02 Termination of a material agreement | 0001213900-25-062803 |
| 2025-06-18 | 19:16 ET | [8-K](/filings/0001213900-25-055334.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-055334 |
| 2025-05-27 | 16:15 ET | [8-K](/filings/0001213900-25-047805.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-047805 |
| 2025-05-12 | 16:06 ET | [10-Q](/filings/0001213900-25-042025.md) | Quarterly report, period 2025-03-31 | 0001213900-25-042025 |
| 2025-05-12 | 16:05 ET | [8-K](/filings/0001213900-25-042024.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-25-042024 |
| 2025-04-28 | 13:18 ET | [8-K](/filings/0001213900-25-035941.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-035941 |
| 2025-04-11 | 16:15 ET | [DEF 14A](/filings/0001213900-25-031088.md) | Proxy statement, period 2025-05-23 | 0001213900-25-031088 |
| 2025-03-27 | 16:42 ET | [8-K](/filings/0001013762-25-003432.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001013762-25-003432 |
| 2025-03-27 | 16:40 ET | [10-K](/filings/0001013762-25-003426.md) | Annual report, period 2024-12-31 | 0001013762-25-003426 |
| 2025-03-26 | 17:00 ET | [8-K](/filings/0001013762-25-002786.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001013762-25-002786 |
| 2025-02-06 | 06:38 ET | [8-K](/filings/0001213900-25-010711.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-010711 |
| 2025-01-27 | 07:30 ET | [8-K](/filings/0001213900-25-006727.md) | 3.01 Delisting notice | 0001213900-25-006727 |
| 2025-01-06 | 17:29 ET | [8-K](/filings/0001213900-25-001249.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-001249 |
| 2024-12-09 | 07:49 ET | [8-K](/filings/0001213900-24-106646.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-106646 |
| 2024-12-04 | 07:30 ET | [8-K](/filings/0001213900-24-105245.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-105245 |
| 2024-11-07 | 16:05 ET | [10-Q](/filings/0001213900-24-095398.md) | Quarterly report, period 2024-09-30 | 0001213900-24-095398 |
| 2024-08-07 | 16:05 ET | [10-Q](/filings/0001213900-24-066111.md) | Quarterly report, period 2024-06-30 | 0001213900-24-066111 |
| 2024-05-30 | 16:05 ET | [8-K](/filings/0001213900-24-047968.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-24-047968 |
| 2024-05-08 | 16:06 ET | [10-Q](/filings/0001213900-24-040856.md) | Quarterly report, period 2024-03-31 | 0001213900-24-040856 |
| 2024-04-09 | 16:10 ET | [DEF 14A](/filings/0001213900-24-031600.md) | Proxy statement, period 2024-05-24 | 0001213900-24-031600 |
| 2024-03-19 | 16:10 ET | [8-K](/filings/0001213900-24-024022.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-024022 |
| 2024-03-19 | 16:05 ET | [10-K](/filings/0001213900-24-024013.md) | Annual report, period 2023-12-31 | 0001213900-24-024013 |
| 2024-01-11 | 16:30 ET | [8-K](/filings/0001213900-24-003000.md) | 5.02 Departure or appointment of officers or directors | 0001213900-24-003000 |
| 2024-01-04 | 08:11 ET | [8-K](/filings/0001213900-24-000999.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-000999 |
| 2024-01-03 | 17:00 ET | [8-K](/filings/0001213900-24-000858.md) | 5.02 Departure or appointment of officers or directors | 0001213900-24-000858 |
| 2023-11-08 | 16:05 ET | [10-Q](/filings/0001213900-23-084737.md) | Quarterly report, period 2023-09-30 | 0001213900-23-084737 |
| 2023-11-08 | 16:01 ET | [8-K](/filings/0001213900-23-084735.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-084735 |

Page 1 of 5. [Older](/companies/rlmd/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.